Peptide Atlas · Peptide

FGL

preclinical

provisional
PubChem 16200289
2 citations
0 discussions
0 followers
FG Loop peptide
FGLL
NCAM-derived FGL

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

preclinical — animal, cell or mechanistic work — not yet about people

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

- preclinical
  Claim: The NCAM-derived FGL peptide is an FGF-receptor agonist promoting neurite outgrowth and survival standing
- resolved
An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons.
Neiiendam JL, Køhler LB, Christensen C, Li S, Pedersen MV, Ditlevsen DK, Kornum MK, Kiselyov VV, Berezin V, Bock E
pmid 15525346
- preclinical
  Claim: FGL protects hippocampal neurons from ischemic injury in vitro and in vivo standing
- resolved
A synthetic NCAM-derived peptide, FGL, protects hippocampal neurons from ischemic insult both in vitro and in vivo.
Skibo GG, Lushnikova IV, Voronin KY, Dmitrieva O, Novikova T, Klementiev B, Vaudano E, Berezin VA, Bock E
pmid 16197499

A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.